Skip to content

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

https://pubmed.ncbi.nlm.nih.gov/33506200/

This experiment tested the effects of Mebendazole on both cancer cells in the laboratory, and on mice with human gliomas attached, and found that the mice given Mebendazole lived significantly longer.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Mebendazole

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments